Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS)

NCT02904265 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02904265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02904265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS)
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2016
Completion date
July 26, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

landau-kleffner syndrome, status epilepticus, electrographic